Calendar of Events
S Sun
M Mon
T Tue
W Wed
T Thu
F Fri
S Sat
0 events,
1 event,
1 event,
0 events,
3 events,
Founders at Work: Siren Biotechnology
Founders at Work: Siren Biotechnology
https://mbcbiolabs.com/wp-content/uploads/2025/03/Siren-Logo_Grey-Red.pngFrom the trenches - what it's like to submit your first data packet to the FDA in 2025At Siren, we are combining the promise of two transformative therapeutic technologies, AAV gene therapy and cytokine immunotherapy, into a single, powerful new treatment modality to fight cancer. Come hear from us about our experience transitioning from a Discovery to a Translational (& about to be Clinical) Stage company and what it's like to engage with the FDA right now. The intent of this time is to be maximally useful to our neighbor companies as we continue to learn from each other. We'll chat about Siren, share some firsthand stories and lessons learned, and close with an 'ask me anything'-style Q&A.Website → Our Speaker https://mbcbiolabs.com/wp-content/uploads/2025/03/Nicole-Paulk.jpgDr. Nicole PaulkDr. Nicole Paulk is the CEO, Founder, and President of Siren Biotechnology and has dedicated her career to advancing the field of gene therapy. Before founding Siren, Nicole held various leadership positions in academia and industry and most notably was an Assistant Professor of AAV Gene Therapy in the UCSF Department of Biochemistry & Biophysics before leaving to found Siren. Nicole has a unique lens into the current biotech environment as an advisor for numerous public and [...]
0 events,
0 events,
0 events,
5 events,
LICOR Virtual Office Hours
LICOR Virtual Office Hours
The office hours are primarily to offer solutions and support towards sample preparation, reagent selection, instrumentation, acquisition, and analysis.
0 events,
0 events,
0 events,
3 events,
0 events,
0 events,
0 events,
0 events,
2 events,
0 events,
0 events,
0 events,
0 events,
2 events,
Founders at Work: TwoStep Therapeutics
Founders at Work: TwoStep Therapeutics
https://mbcbiolabs.com/wp-content/uploads/2025/04/TwoStep-Therapeutics-Logo.svgIntroduction to TwoStep Therapeutics and Fireside ChatTwoStep Therapeutics is a biotechnology company developing a pipeline built around a versatile targeting peptide “PIP” that binds selectively to multiple tumor-associated integrins, a unique feature that enables it to deliver various payloads to virtually any solid tumor. The company leverages this technology to create targeted cancer therapies for drug delivery and radioligand therapy. TwoStep Therapeutics was co-founded by CEO, Caitlyn Miller, in collaboration with world-renowned academic entrepreneurs at Stanford University, including Nobel Laureate Carolyn Bertozzi, Jennifer Cochran, and Ronald Levy. Come learn more about TwoStep Therapeutics, including an ‘ask me anything’-style Q&A at the end.Website → Our Speaker https://mbcbiolabs.com/wp-content/uploads/2025/04/CaitlynMiller_Headshot-300x200.jpg Dr. Caitlyn Miller Caitlyn Miller, PhD, co-founder and CEO of TwoStep Therapeutics, is dedicated to the company’s mission of bringing innovative targeted therapies to patients. Dr. Miller received her PhD in Bioengineering from Stanford University in the labs of Dr. Carolyn Bertozzi and Dr. Jennifer Cochran. During her PhD and postdoctoral work, Dr. Miller played a pivotal role in advancing technology that is now integrated into TwoStep’s therapeutic pipeline. Dr. Miller then joined the Stanford Innovative Medicines Accelerator as an Entrepreneur-In-Residence, where she spearheaded the launch of TwoStep Therapeutics. Register here →